AOD-9604 Dosage Guide: How Much Should You Take? (2026)
Key Takeaways Standard Dosage Range: Typically 500 mcg to 1 mg per day for research purposes. Administration Method: Primarily subcutaneous injection, with specific protocols for frequency and site rotation. Typical Cycle Length: Often ranges from 4 to 12 week
Key Takeaways
Standard Dosage Range: Typically 500 mcg to 1 mg per day for research purposes.
Administration Method: Primarily subcutaneous injection, with specific protocols for frequency and site rotation.
Typical Cycle Length: Often ranges from 4 to 12 weeks, depending on research goals.
Regulatory Status: Not FDA-approved; available for research only.
Medical Supervision: Essential to ensure safe and effective use, considering individual variability and potential side effects.
How AOD-9604 Works in the Body
AOD-9604 is a synthetic analog of the human growth hormone (hGH), specifically comprising amino acids 177–191. Its mechanism of action is primarily through the modulation of lipid and glucose metabolism pathways. This peptide functions by activating β-adrenergic and AMPK-related mechanisms, which play a critical role in metabolic processes.
The pharmacokinetic properties of AOD-9604, including its receptor binding affinity and half-life, significantly influence dosing decisions. The peptide exhibits a relatively short half-life, necessitating frequent administration to maintain effective plasma levels. Its bioavailability is also a critical consideration, as it varies with the route of administration.
"AOD-9604 has been shown to influence metabolic pathways, making it a candidate for obesity treatment in preclinical studies" (PMID 15134286).
Understanding these mechanisms is crucial for determining the appropriate dosage, as they directly impact the peptide's effectiveness and safety profile.
Standard AOD-9604 Dosage Ranges (By Form)
Subcutaneous Injection
Dosage Range: Typically 500 mcg to 1 mg per day.
Frequency: Once daily is common, although some protocols may recommend twice daily.
Bioavailability: High, due to direct absorption into the bloodstream.
Prevalence: Most common form due to its efficacy and ease of administration.
Intramuscular Injection
Dosage Range: Similar to subcutaneous, but less commonly used.
Frequency: Once daily.
Bioavailability: Comparable to subcutaneous but may vary slightly based on muscle tissue absorption.
Oral and Other Forms
Note: Oral and topical forms are less common due to significantly reduced bioavailability. Research primarily focuses on injectable forms.
Prescribing information and clinical trial protocols often prefer subcutaneous administration for its balance of efficacy and convenience.
AOD-9604 Dosage by Use Case
Obesity and Weight Management
Typical Dosage Range: 500 mcg to 1 mg daily.
Administration Method: Subcutaneous injection.
Cycle Length: 8 to 12 weeks, with reassessment based on research outcomes.
Study Reference: Preclinical trials indicate potential in obesity management (PMID 16625817).
Metabolic Research
Cycle Length: 4 to 8 weeks, often adjusted based on metabolic markers.
Clinical Protocols: Many research protocols utilize this range to investigate metabolic effects.
Adipocyte Differentiation Studies
Cycle Length: 6 to 10 weeks, focusing on cellular differentiation outcomes.
Research Basis: Studies suggest modulation of adipocyte pathways (PMID 24124033).
How Long Should You Take AOD-9604?
The duration of AOD-9604 administration varies based on research objectives. Typical cycles range from 4 to 12 weeks. Initial effects may be observed within the first few weeks, with more pronounced outcomes by week 6. Tapering is generally not required, but cessation should be managed under supervision to monitor any rebound effects.
Administration Protocol: How to Take AOD-9604
Injection Technique
Needle Gauge: 29-31 gauge insulin syringe.
Injection Sites: Rotate between abdomen, thigh, and upper arm.
Rotation Schedule: Rotate sites daily to minimize tissue irritation.
Storage Requirements
Temperature: Store at 2-8°C (refrigerator); avoid freezing.
Light Sensitivity: Protect from light exposure.
Reconstituted Stability: Use within 14 days of reconstitution.
Reconstitution Instructions
Diluent: Use bacteriostatic water for injection.
Process: Slowly inject diluent into the vial, avoiding agitation.
Step-by-Step Administration
Prepare the Injection: Reconstitute and draw the appropriate dose into the syringe.
Select Injection Site: Choose a site with sufficient subcutaneous fat.
Inject Slowly: Insert the needle at a 45-degree angle and inject the solution.
Dispose of Materials: Safely discard the syringe and needle.
For detailed reconstitution guidance, refer to our reconstitution guide.
Stacking AOD-9604 for Better Results
Common Stacks
AOD-9604 + CJC-1295: Enhances growth hormone release. Typical dosing synergy involves alternating administrations.
AOD-9604 + Ipamorelin: Synergistic effects on metabolic pathways. Commonly used in metabolic research protocols.
These combinations are often part of research protocols aiming to enhance metabolic and adipogenic effects.
Factors That Affect Your AOD-9604 Dosage
Several factors influence the appropriate dosage of AOD-9604:
Body Weight: Higher doses may be required for larger individuals.
Age: Metabolic rate and hormonal balance may necessitate dosage adjustments.
Treatment Goals: Specific research objectives dictate dosing protocols.
Kidney/Liver Function: Impaired function may require dose modification.
Other Medications: Potential interactions should be evaluated by a healthcare provider.
Common Dosing Mistakes to Avoid
Dosing Too High/Too Low: Adjust based on individual response and research goals.
Inconsistent Timing: Maintain a consistent schedule to ensure stable plasma levels.
Wrong Injection Site: Rotate sites to avoid tissue damage.
Not Accounting for Regulatory Status: Use only in approved research contexts.
Poor Storage/Handling: Follow storage guidelines to maintain peptide stability.
What the Evidence Does Not Show
Current evidence is primarily preclinical, with limited human trials. Long-term safety data are lacking, and dose-response relationships are still under investigation. AOD-9604's use remains restricted to research settings, emphasizing the need for ongoing studies.
FAQ — Your Top AOD-9604 Dosage Questions Answered
Best time of day to take it? There is no specific time, but consistency is key. Many opt for morning injections.
What if you miss a dose? Administer as soon as remembered, but skip if close to the next scheduled dose.
Can men and women use the same dose? Yes, dosing is typically based on research goals rather than gender.
Can you stack it with other peptides? Yes, common stacks include CJC-1295 and Ipamorelin.
How long until you see results? Initial effects may appear within weeks, with more noticeable outcomes by week 6.
Do you need to cycle off? Cycling off is not mandatory, but periodic reassessment is advised.
Is a loading dose needed? No loading dose is required for AOD-9604.
How to adjust dose if side effects occur? Consult a healthcare provider to evaluate and adjust the dose accordingly.
Conclusion — Finding the Right Dosage for You
Determining the optimal AOD-9604 dosage involves careful consideration of individual factors and research objectives. Medical supervision is crucial to ensure safe and effective administration. For more information, explore our peptide encyclopedia and use our clinic finder to locate a qualified provider near you.
Medical Disclaimer — "This content is for informational purposes only and does not constitute medical advice. Dosage information is compiled from published research and clinical protocols. Consult a licensed healthcare provider before starting any peptide therapy. Use our clinic finder to locate a qualified provider near you."